Capsule containing probiotics and traditional Chinese medicine extract

Abstract

The utility model discloses a capsule containing probiotics and traditional Chinese medicine extracts, and particularly relates to the technical field of capsules, the capsule comprises a first capsule shell I, the rear end of the first capsule shell I is movably connected with a first capsule shell II, and an inner cavity of the first capsule shell I is fixedly connected with an isolation plate and a locking plate; the inner cavity of the locking plate is movably connected with a second capsule. According to the capsule containing the probiotics and the traditional Chinese medicine extracts, the capsule II is designed, so that various kinds of medicine powder can be filled, the medicine property is effectively prevented from being influenced by medicine mixing, when the capsule is swallowed into the abdomen by a human body, a sugar coating wrapping the capsule can prevent the capsule from being quickly corroded by gastric acid, and when the capsule enters the intestinal tract of a patient, the capsule is prevented from being damaged. After the first capsule shell I and the first capsule shell II start to dissolve, the internal medicine powder starts to dissolve and is absorbed by the human body, and after a period of time, the capsule II starts to dissolve, so that the medicine powder in the capsule II is further absorbed by the human body, and the medicine effect is improved.

Description

Technical Field

[0001] The utility model relates to the technical field of capsules, in particular to a capsule containing probiotics and traditional Chinese medicine extracts. Background Technique

[0002] Drug capsules are a common drug dosage form, usually used for administering and taking drugs. It consists of two parts: an outer shell and an internal filling. The outer shell is usually made of materials such as gelatin or vegetable cellulose, while the internal filling contains the drug itself and possible excipients. Among them, enteric-coated capsules are a special design of drug dosage form, whose outer shell material can not be dissolved under the influence of gastric acid, but will dissolve and release the drug in the more alkaline small intestine part.

[0003] Chinese patent document CN218280127U discloses an enteric-coated hollow capsule, which includes a first capsule shell and a second capsule shell, and the first capsule shell and the second capsule shell are butted to form a complete hollow capsule. An extension part is integrally arranged at the opening of the first capsule shell, and an outward-turning edge is integrally connected to the port of the extension part. At the same time, an inward-turning edge is integrally connected to the inner wall of the second capsule shell. Inner shells are integrally arranged in both the first capsule shell and the second capsule shell. By setting flanges at the connection of the two capsule shells and using the flanges to buckle, the two capsule shells can be tightly connected together. Thus, when swallowing the capsule, even if the capsule is wetted by water and then squeezed through the esophagus, it can still be well connected together without generating gaps. In this way, when the capsule enters the stomach, it can play a good sealing role, and gastric juice will not enter the inside of the capsule along the gaps, causing the capsule to soften quickly and resulting in the internal powder being decomposed and absorbed in the stomach.

[0004] The above patent document can ensure that the capsule remains sealed until it enters the intestine when it enters the stomach. However, the existing drug capsules can only store a single drug and cannot put different drugs that do not cause pharmacological conflicts into the same capsule, which is not convenient for patients to take and control the drug dosage. Content of the Utility Model

[0005] The main purpose of the utility model is to provide a capsule containing probiotics and traditional Chinese medicine extracts, which can effectively solve the problem that different drugs that do not cause pharmacological conflicts cannot be put into the same capsule.

[0006] To achieve the above purpose, the technical solution adopted by the utility model is as follows:

[0007] A capsule containing probiotics and traditional Chinese medicine extracts includes a first capsule shell one. The rear end of the first capsule shell one is movably connected to a first capsule shell two. A partition board and a locking board are fixedly connected to the inner cavity of the first capsule shell one. A capsule two is movably connected to the inner cavity of the locking board.

[0008] Preferably, the first capsule shell two includes a housing one, the rear end of the first capsule shell one is engaged with the front end of the housing one, a connecting ring one is fixedly connected to the front end of the housing one, and a convex ring one is fixedly connected to the outer surface of the connecting ring one.

[0009] Preferably, the capsule two includes a second capsule shell one and a lock catch plate, the second capsule shell one is movably connected in the inner cavity of the first capsule shell one, a second capsule shell two is movably connected to the open end of the second capsule shell one, a lock catch plate is fixedly connected to the outer surface of the second capsule shell one, and a plurality of buckles are fixedly connected to one end of the lock catch plate.

[0010] Preferably, the second capsule shell one includes a housing two, the housing two is fixedly connected to the inner cavity of the lock catch plate, and a limiting groove is provided in the inner cavity of the housing two.

[0011] Preferably, the second capsule shell two includes a housing three, the open end of the housing three is movably connected to the open end of the housing two, a connecting ring two is fixedly connected to the open end of the housing three, and a convex ring two is fixedly connected to the outer surface of the connecting ring two.

[0012] Preferably, a plurality of through holes are provided in the isolation plate, and a plurality of limiting holes matching the buckles are provided in the locking plate.

[0013] Preferably, the outer surfaces of the first capsule shell one and the housing one are both coated with sugar coating, and a positioning groove matching the convex ring one is provided in the inner cavity of the first capsule shell one.

[0014] Compared with the prior art, the utility model has the following beneficial effects:

[0015] 1. The utility model can realize the loading of various medicated powders through the provided capsule two, effectively avoiding the influence of drug mixing on the drug property. When the capsule is swallowed by the human body, the outer sugar coating can prevent the gastric acid from quickly corroding the capsule. When the capsule enters the patient's intestine, the first capsule shell one and the first capsule shell two begin to dissolve, and at this time, the internal medicated powder begins to dissolve and is absorbed by the human body. After a period of time, the capsule two begins to dissolve, enabling the medicated powder inside the capsule two to be further absorbed by the human body, thereby improving the drug efficacy.

[0016] 2. The utility model can effectively ensure the installation and removal of the isolation plate and the locking plate through the provided structure, and can decide whether to install the capsule two according to the actual situation or the drug use effect, improving the selectivity of the drug and facilitating production and use. BRIEF DESCRIPTION OF THE DRAWINGS

[0017] Figure 1 is a schematic diagram of the overall structure of the utility model;

[0018] Figure 2Schematic diagram of the overall structure of another perspective of the present utility model;

[0019] Figure 3 Schematic diagram of the sectional view of the partial structure of the present utility model;

[0020] Figure 4 Schematic diagram of the second capsule structure of the present utility model;

[0021] Figure 5 For the present utility model Figure 2 Enlarged schematic diagram at position A;

[0022] Figure 6 For the present utility model Figure 4 Enlarged schematic diagram at position B.

[0023] In the figure: 1. The first capsule shell one; 2. The first capsule shell two; 21. The shell one; 22. The connecting ring one; 23. The convex ring one; 3. The isolation plate; 4. The locking plate; 5. The capsule two; 51. The second capsule shell one; 511. The shell two; 512. The limiting groove; 52. The second capsule shell two; 521. The shell three; 522. The connecting ring two; 523. The convex ring two; 53. The lock buckling plate; 54. The buckle. Specific embodiments

[0024] In order to make the technical means, creative features, achieved purposes and functions of the present utility model easy to understand, the present utility model will be further described below in conjunction with specific embodiments.

[0025] All components used in this solution can be absorbed and digested by the human body. It is mainly composed of materials such as probiotics and traditional Chinese medicine extracts. Probiotics are a class of active microorganisms beneficial to the host, which can stimulate the intestinal immune function and help patients with poor gastrointestinal function absorb drugs better. The traditional Chinese medicine extract mainly plays an auxiliary conditioning role, and its main components only need to meet the requirement of not affecting drug absorption.

[0026] As Figure 1 , Figure 2 And Figure 5 shown, a capsule containing probiotics and traditional Chinese medicine extracts includes a first capsule shell one 1, and the first capsule shell two 2 is movably connected to the rear end of the first capsule shell one 1. The first capsule shell two 2 includes a shell one 21. The front end of the first capsule shell one 1 is engaged with the front end of the shell one 21. A connecting ring one 22 is fixedly connected to the front end of the shell one 21, and a convex ring one 23 is fixedly connected to the outer surface of the connecting ring one 22. A positioning groove matching with the convex ring one 23 is opened in the inner cavity of the first capsule shell one 1;

[0027] During the installation process, only the openings of the first capsule shell 1 and the second capsule shell 2 need to be aligned with each other, so that the first connecting ring 22 enters the inner cavity of the first capsule shell 1. When the convex ring 23 on the outer surface of the first connecting ring 22 engages with the positioning groove in the inner cavity of the first capsule shell 1 to complete the fixation, the first capsule shell 1 and the second capsule shell 2 will not separate before reaching the patient's stomach and intestines, facilitating the capsule to smoothly enter the stomach and intestines for absorption.

[0028] As Figure 3 shown, a partition plate 3 and a locking plate 4 are fixedly connected to the inner cavity of the first capsule shell 1. A second capsule 5 is movably connected to the inner cavity of the locking plate 4. The partition plate 3 can support one end of the second capsule 5 and prevent the leakage of drug particles at the same time. The locking plate 4 facilitates the fixation of the second capsule 5.

[0029] As Figure 4 and Figure 6 shown, the second capsule 5 includes a first second capsule shell 51 and a lock catch plate 53. The first second capsule shell 51 is movably connected to the inner cavity of the first capsule shell 1. The first second capsule shell 51 includes a second shell 511, and the second shell 511 is fixedly connected to the inner cavity of the lock catch plate 53. A limiting groove 512 is opened in the inner cavity of the second shell 511. A second second capsule shell 52 is movably connected to the open end of the first second capsule shell 51. The second second capsule shell 52 includes a third shell 521, and the open end of the third shell 521 is movably connected to the open end of the second shell 511. A second connecting ring 522 is fixedly connected to the open end of the third shell 521, and a convex ring 523 is fixedly connected to the outer surface of the second connecting ring 522. A lock catch plate 53 is fixedly connected to the outer surface of the first second capsule shell 51. A plurality of buckles 54 are fixedly connected to one end of the lock catch plate 53. A plurality of through holes are opened in the partition plate 3, and the diameter of these through holes is smaller than that of the drug particles, which mainly plays a role in separating the drugs and facilitating subsequent absorption and digestion in the intestines. A plurality of limiting holes matching the buckles 54 are opened on the locking plate 4;

[0030] During the process of filling the medicine, the medicine powder or drug particles need to be filled into the first second capsule shell 51 or the second second capsule shell 52, and then the second connecting ring 522 is inserted into the inner cavity of the second shell 511 so that the convex ring 523 engages with the limiting groove 512 for fixation. At this time, the filling of the second capsule 5 is completed. Then, the second capsule 5 is placed into the inner cavity of the first capsule shell 1. After that, the buckles 54 are passed through the limiting holes and then the second capsule 5 is rotated to fix and engage the buckles 54 with the locking plate 4. This fixation is stable and will not separate due to the patient's swallowing or violent shaking. The materials of the first second capsule shell 51 and the second second capsule shell 52 can be decomposed in the intestines, facilitating human absorption.

[0031] As Figure 1As shown, the outer surfaces of the first capsule shell 1 and the first housing 21 are both coated with sugar coating, which can improve the taste of the medicine and facilitate the patient's swallowing. At the same time, the material of the sugar coating can slow down the corrosion of the capsule by gastric acid, facilitating the capsule to enter the stomach and intestines for decomposition and absorption.

[0032] The working principle of the present utility model is as follows: First, fill the medicine powder or medicine granules into the second capsule shell 1 51 or the second capsule shell 2 52. Then, insert the second connecting ring 522 into the inner cavity of the second housing 511 so that the second convex ring 523 is engaged and fixed with the limiting groove 512. After that, place the second capsule 5 into the inner cavity of the first capsule shell 1. Then, pass the buckle 54 through the limiting hole and rotate the second capsule 5 to fix and engage the buckle 54 with the locking plate 4. Next, fill other medicines into the first housing 21. After filling, align the openings of the first capsule shell 1 and the second capsule shell 2 so that the first connecting ring 22 enters the inner cavity of the first capsule shell 1. When the first convex ring 23 on the outer surface of the first connecting ring 22 is engaged with the positioning groove in the inner cavity of the first capsule shell 1, the fixation is completed.

[0033] The above shows and describes the basic principles, main features and advantages of the present utility model. Those skilled in the art should understand that the present utility model is not limited by the above embodiments. The above embodiments and the descriptions in the specification only illustrate the principles of the present utility model. Without departing from the spirit and scope of the present utility model, the present utility model will have various changes and improvements, and these changes and improvements all fall within the scope of the present utility model claimed. The scope of protection claimed by the present utility model is defined by the appended claims and their equivalents.

Claims

1. A capsule containing probiotics and Chinese herbal medicine extracts, comprising a first capsule shell (1), characterized in that: The rear end of the first capsule shell one (1) is movably connected to the first capsule shell two (2); the inner cavity of the first capsule shell one (1) is fixedly connected to an isolation plate (3) and a locking plate (4); the inner cavity of the locking plate (4) is movably connected to capsule two (5).

2. The capsule containing probiotics and Chinese medicine extract according to claim 1, characterized in that: The first capsule shell 2 (2) comprises a shell 1 (21), the rear end of the first capsule shell 1 (1) and the front end of the shell 1 (21) are mutually engaged, the front end of the shell 1 (21) is fixedly connected with a connecting ring 1 (22), and the outer surface of the connecting ring 1 (22) is fixedly connected with a convex ring 1 (23).

3. The capsule containing probiotics and Chinese medicine extract according to claim 1, characterized in that: The capsule 2 (5) comprises a second capsule shell 1 (51) and a locking plate (53); the second capsule shell 1 (51) is movably connected to the inner cavity of the first capsule shell 1 (1); the opening end of the second capsule shell 1 (51) is movably connected to the second capsule shell 2 (52); the outer surface of the second capsule shell 1 (51) is fixedly connected to the locking plate (53); one end of the locking plate (53) is fixedly connected to a plurality of buckles (54).

4. The capsule containing probiotics and Chinese medicine extract according to claim 3, characterized in that: The second capsule shell 1 (51) comprises a shell 2 (511), wherein the shell 2 (511) is fixedly connected to the inner cavity of the locking plate (53), and a limiting groove (512) is provided in the inner cavity of the shell 2 (511).

5. The capsule containing probiotics and Chinese medicine extract according to claim 4, characterized in that: The second capsule shell 2 (52) includes a shell 3 (521), the open end of the shell 3 (521) is movably connected to the open end of the shell 2 (511), the open end of the shell 3 (521) is fixedly connected to a connecting ring 2 (522), and the outer surface of the connecting ring 2 (522) is fixedly connected to a convex ring 2 (523).

6. The capsule containing probiotics and Chinese medicine extract according to claim 3, characterized in that: The isolation plate (3) is provided with a plurality of through holes therein, and the locking plate (4) is provided with a plurality of limiting holes matching the buckles (54).

7. The capsule containing probiotics and Chinese medicine extract according to claim 2, characterized in that: The outer surfaces of the first capsule shell (1) and the shell (21) are both coated with sugar coating, and the inner cavity of the first capsule shell (1) is provided with a positioning groove matching the convex ring (23).

Images